Scatter Plot from Scientific Research

Fraction of CD16 + neutrophil granulocytes (left), CD14 + monocytes (center) and CD4 + CD25 + regulatory T cells (T reg , right) in single-cell suspensions from resected tumors. Each dot or box represents a single patient (black, nivolumab; red, nivolumab and relatlimab; MPR, ≤10% viable tumor cells in resected tumors and lymph nodes; no MPR, >10% viable tumor cells). Horizontal lines indicate the mean and s.e.m.

DOI